Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience

• by Taha, Nourhan Abdelmohsen, Gomaa, Manar Abdelazeem, Helmy, Shahinaz Mohamed, Farag, Sherien Mohamed, Moustafa, Ramez Reda

• June 3, 2026

Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine

• by Elif Ilgaz Aydınlar, Pınar Yalınay Dikmen, Aysenur Sahin, Kerem Birısık

• June 1, 2026

Visual Snow Challenges Diagnosis

A case highlights persistent visual symptoms despite normal testing and suggests a neurofunctional origin.

• by Andrea Surnit

• April 1, 2026

• 3 min

Can Migraine Care Be Reliably Measured?

ACP review finds existing metrics inadequate and identifies data gaps that limit performance measurement.

• by Andrea Surnit

• April 20, 2026

• 3 min